Clinical trial
An Investigational Study Drug, Palbociclib (PD-0332991), Is Being Studied In…
NCT00420056 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00420056 |
|---|---|
| Title | An Investigational Study Drug, Palbociclib (PD-0332991), Is Being Studied In Patients With Mantle Cell Lymphoma. Patients Must Have Received Prior Treatment(s) For Mantle Cell Lymphoma. |
| Official title | A Pilot Study Of Pd 0332991 In Patients With Previously Treated Mantle Cell Lymphoma |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Lymphoma, Mantle-Cell |
| Intervention type | Drug |
| Interventions | PD-0332991 |
| Enrollment | 17 |
| Start date | May 1, 2007 |
| Primary completion | Mar 1, 2010 |
| Completion | Mar 1, 2012 |
| First posted | Jan 9, 2007 |
| Last update posted | Oct 28, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: